Quinazolinones as bromodomain inhibitors
US9855271B2 · kind B2 · utility
13Cited by
25References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2014 |
| Grant date | Jan 2, 2018 |
| Priority date | — |
| Expiry date | Jul 30, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.